Indivior Plc (INDV)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Indivior Plc Stock (INDV) Company Profile

Indivior Plc

Healthcare (1170)

804-379-1090

234 BATH ROAD, SLOUGH, BERKSHIRE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INDV's Discussions on Twitter

Vergleichen Sie INDV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INDV Indivior Plc	13.01	1.48B	1.12B	5.00M	-383.00M	0.01
HLN Haleon Plc Adr	11.14	50.54B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	170.62	74.02B	9.29B	2.52B	2.28B	5.57
RDHL Redhill Biopharma Ltd Adr	1.8368	4.22M	35.75M	11.57M	-26.25M	-3.8069
TAK Takeda Pharmaceutical Co Adr	14.98	45.82B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	17.30	20.31B	16.54B	-1.64B	749.00M	-1.45

Indivior Plc Stock (INDV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-28	Eingeleitet	Rodman & Renshaw	Buy
2024-07-23	Eingeleitet	Piper Sandler	Overweight
2024-04-03	Eingeleitet	Craig Hallum	Buy
2023-07-13	Eingeleitet	Northland Capital	Outperform

Indivior Plc Aktie (INDV) Neueste Nachrichten

Finanzdaten der Indivior Plc-Aktie (INDV)

Indivior Plc (INDV)

Indivior Plc Stock (INDV) Company Profile

Vergleichen Sie INDV mit anderen Aktien

Indivior Plc Stock (INDV) Upgrades & Downgrades

Indivior Plc Aktie (INDV) Neueste Nachrichten

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo

Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media

Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd

Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine

Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media

Kalkine: Indivior Exits London as FTSE 100 Firm Focuses on Nasdaq - Kalkine Media

FTSE pharma giant joins London stock market exodus - The Telegraph

Indivior (INDV) Delists from London to Focus on U.S. Market - GuruFocus

Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN

Indivior brings curtain down on turbulent 11-year run in London - Proactive financial news

Indivior drops London listing to focus on U.S. market By Investing.com - Investing.com Nigeria

Indivior To Delist From LSE To Better Align With US Focused Business - Nasdaq

Indivior to cancel secondary listing in London - Sharecast.com

Indivior Plans to Cancel London Listing After Moving Primary to US - Bloomberg

Drug maker Indivior to abandon London stock market for the US - Yahoo

Indivior to Cancel London Stock Exchange Listing, Focuses on Nasdaq - TipRanks

Indivior to Cancel Secondary Listing on London Stock Exchange, Maintains Primary Nasdaq Listing | Indivior Stock News - paginasiete.bo

Indivior to delist from London Stock Exchange, maintain Nasdaq listing - marketscreener.com

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - Bluefield Daily Telegraph

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire

Indivior Announces Patrick Barry as Chief Commercial Officer - The Malaysian Reserve

Indivior appoints Patrick Barry as Chief Commercial Officer By Investing.com - Investing.com South Africa

Indivior Announces Patrick Barry as Chief Commercial Officer | I - GuruFocus

Indivior Announces Patrick Barry as Chief Commercial Officer | INDV Stock News - GuruFocus

Indivior Taps Former Endo Executive to Drive SUBLOCADE Growth Strategy - Stock Titan

Indivior PLC (INDV) Stock Analysis: A 30% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews

Investors in Indivior (LON:INDV) have seen solid returns of 156% over the past five years - Yahoo Finance

How To Trade (INDV) - news.stocktradersdaily.com

Indivior PLC (LON:INDV) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st

Naloxone Market Projected To Witness Massive Growth, 2025-2032 - openPR.com

Court of Appeal upholds representative action strike out in Wirral Council v Indivior/Reckitt, but claimant applies for permission to appeal to Supreme Court - stewartslaw.com

Indivior PLC Aligns CEO Compensation with Long-Term Performance Goals - TipRanks

Indivior to Participate in Upcoming Investor Events - StreetInsider

Indivior to Participate in Upcoming Investor Events | INDV Stock News - GuruFocus

Indivior announces participation in investor conferences By Investing.com - Investing.com India

Indivior to Engage with Investors at Key Healthcare Conferences - TipRanks

Indivior to Participate in Upcoming Investor Events – Company Announcement - Financial Times

Drug Addiction Treatment Market Projected To Witness Massive - openPR.com

(INDV) Long Term Investment Analysis - news.stocktradersdaily.com

Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com

Indivior advances GABA-B PAM program for substance use disorders through IND-enabling studies - BioWorld MedTech

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - Yahoo

Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Indivior PLC (INDV) - ACCESS Newswire

Indivior PLC Announces AGM Results with Key Resolutions Passed - TipRanks

Indivior PLC Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationINDV - ACCESS Newswire

Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire

Finanzdaten der Indivior Plc-Aktie (INDV)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INDV